The overall objective of this research was to investigate the status of tumor necrosis factor-?? (TNF-??), and molecules associated with its signaling, in the pathological state of hepatic steatosis. The effect of NSAID piroxicam, a cancer preventive agent also known to affect TNF-?? signaling on hepatic steatosis, was also investigated. The biological state of the tissue was assessed by examining the expression of TNF-?? signaling molecule in whole tissue, as well as in hepatic lipid raft. Lipid rafts are dynamic assemblies of cholesterol and sphingolipids, microdomains that form in the exoplasmic leaflet of the biological membranes shown to play a role in compartmentalization, modulation and integration of the cell signaling. In the present research, Zucker obese rats were used as a model of human obesity and insulin resistant state. These rats exhibit hepatic steatosis in adulthood similar to those noted in obese individuals. Female Zucker obese and lean rats (5 weeks old) were fed a semisynthetic diet with or without piroxicam (150 ppm). Zucker lean counterparts served as control. After 8 weeks of feeding, rats were euthanized and liver from each animal was collected. Liver tissue from each animal was processed for histology and biochemical analysis which included lipids and proteins (COX-1 and 2, TNF-??, TNF-RI and RII, IKK-??, I??B-?? and NF-??B). Liver histology and the level of total lipids confirmed that Zucker obese rats had hepatic steatosis, which was further augmented by piroxicam treatment. Whole tissue protein expression, using western blot, showed that the steatotic liver differed from non-steatotic livers by having lower levels of TNF-RII. TNF-RII showed a trend which was inversely proportional to the pathological state of the tissue. The obese-piroxicam liver had the lowest level of TNF-RII and lean livers had the highest (p<0.05). The total NF-??B level was higher in the obese and obese-piroxicam groups compared to the lean or lean-piroxicam groups (p<0.05). Piroxicam treatment lowered the level of NF-??B in obese and lean livers. I??B-?? was higher in obese livers than in lean livers. The nuclear level of NF-??B by western blot analysis showed the same pattern as noted in the whole tissue homogenate. However, the difference in the level between obese and lean was marked. The obese nuclei contained two to three fold higher levels of NF-??B protein than the lean liver nuclei. I??B-?? level was significantly higher in the obese liver tissues and nuclei than their lean counterparts. While transcriptionally active NF-??B was higher (p<0.05) in the obese livers than in the lean livers, the difference between obese and lean groups was not as significant as that noted for the level of NF-??B assessed by western blot. This suggests that the proportion of active NF-??B present in the nuclear fraction is much higher in the lean than in the obese nuclei. Lipid raft was extracted and identified successfully from obese and lean livers. The total caveolin and flotillin levels were significantly higher in the liver lipid rafts of the obese-piroxicam than that of the other groups. This is the group that also exhibited higher steatosis. Piroxicam treatment significantly decreased the level of caveolin in the lean liver and significantly increased the level of flotillin in the obese liver. While COX-1 was not detectable, however, the level of COX-2 and TNF-RII in lipid raft was opposite to the level noted in the whole tissue homogenate. TNFRII was highest in the obese-piroxicam lipid raft and lowest in the lean-piroxicam lipid raft. TNF-RII, COX-2, I??B-?? and NF-??B proteins were the molecules profoundly affected by the pathological state of the tissue and piroxicam treatment. This research is the first to report the presence of I??B-?? in the nuclear compartment with a higher level in the nuclei and whole tissue in the obese liver than in the lean liver. This research demonstrates that TNF-?? to NF-??B axis is altered in steatotic liver, and analysis of lipid rafts in steatotic and non-steatotic liver demonstrates that lipid rafts play a distinct role in modifying the biological availability of key proteins in the pathological state of liver steatosis.

The proventriculus regulates the food passage from crop to midgut. As the haemolymph provides a constantly updated indication of an insect’s nutritional state, it is assumed that the factor controlling the proventri-culus activity is to be found in the haemolymph. The purpose of this doctoral thesis was to investigate how output (metabolic rate), input (food quality and food quantity) and internal state variables (haemolymph osmolarity and haemolymph sugar titer) affect each other and which of these factors controls the activity of the proventriculus in the honeybee. Therefore free-flying foragers were trained to collect con-trolled amounts of different sugar solutions. Immediately after feeding, metabolic rates were measured over different periods of time, then crop-emptying rates and haemolymph sugar titers were measured for the same individual bees. Under all investigated conditions, both the sugar transport rates through the proventriculus and the haemolyph sugar titers depended mainly on the metabolism. For bees collecting controlled amounts of 15 per cent, 30 per cent or 50 per cent sucrose solution haemolymph trehalose, glucose and fructose titers were constant for metabolic rates from 0 to 4.5 mlCO2/h. At higher metabolic rates, trehalose concentration decreased while that of glucose and fructose increased with the exception of bees fed 15 per cent sucrose solution. As the supply of sugar from the crop via the proventriculus was sufficient to support even the highest metabolic rates, the observed pattern must result from an upper limit in the capacity of the fat body to synthesise trehalose. The maximal rate of conversion of glucose to trehalose in the fat body was therefore calculated to average 92.4 µg glucose/min. However, for bees fed 15 per cent sucrose solution both the rate of conversion of glucose to trehalose and the rate of sugar transport from the crop to the midgut were limited, causing an overall decrease in total haemolymph sugar titers for metabolic rates higher than 5 mlCO2/h. Haemolymph sucrose titers were generally low but increased with increasing metabolic rates, even though sucrose was not always detected in bees with high metabolic rates. Though foragers were able to adjust their sugar transport rates precisely to their metabolic rates, a fixed surplus of sugars was transported through the proventriculus under specific feed-ing conditions. This fixed amount of sugars increased with increasing concentration and in-creasing quantity of fed sugar solution, but decreased with progressing time after feeding. This fixed amount of sugars was independent of the metabolic rates of the bees and of the molarity and viscosity of the fed sugar solution. As long as the bees did not exhaust their crop content, the haemolymph sugar titers were unaffected by the sugar surplus, by the time after feeding, by the concentration and by the viscosity of fed sugar solution. When bees were fed pure glucose (or fructose) solutions, un-usually little fructose (or glucose) was found in the haemolymph, leading to lower total haemolymph sugar titers, while the trehalose titer remained unaffected. In order to investigate the mechanisms underlying the regulation of the honeybee proven-triculus, foraging bees were injected either with metabolisable (glucose, fructose, trehalose), or non-metabolisable sugars (sorbose). Bees reacted to injections of metabolisable sugars with reduced crop-emptying rates, but injection of non-metabolisable sugars had no influence on crop emptying. Therefore it is concluded that the proventriculus regulation is controlled by the concentration of metabolisable compounds in the haemolymph, and not by the haemo-lymph osmolarity. A period of 10min was enough to observe reduced crop emptying rates after injections. It is suggested that glucose and fructose have an effect on the proventriculus activity only via their transformation to trehalose. However, when the bees were already in-jected 5min after feeding, no response was detectable. In addition it was investigated whether the overregulation is the result of feed-forward regulation for the imminent take-off and flight. In a first experiment, we investigated whether the bees release an extra amount of sugar solution very shortly before leaving for the hive. In a second experiment, it was tested whether the distance covered by the bees might have an influence on the surplus amount released prior to the take-off. In a third experiment, it was investigated if walking bees fail to release this extra amount of sugars, as they do not have to fly. Though we were not able to demonstrate that the overregulation is the result of feed-forward regulation for the imminent take-off and flight, it is conceivable that this phenome-non is a fixed reaction in foragers that can not be modulated. To investigate whether regulated haemolymph sugar titers are also observed in honeybee foragers returning from natural food sources, their crop contents and haemolymph sugar titers were investigated. While the quantity of the collected nectar was without influence on the haemolymph sugar titers, foragers showed increasing haemolymph sugar titers of glucose, fructose and sucrose with increasing sugar concentration of the carried nectar. In contrast no relationship between crop nectar concentrations and haemolymph trehalose titers was observed. We are sure that the regulation of food passage from crop to midgut is controlled by the trehalose titer. However, under some conditions the balance between consumption and income is not numerically exact. This imprecision depends on the factors which have an impact on the foraging energetics of the bees but are independent of those without influence on the foraging energetics. Therefore we would assume that the proventriculus activity is modulated by the motivational state of the bees. / Der Proventrikel reguliert den Nahrungstransport vom Kropf zum Mitteldarm. Da die Hämolymphe einen stets aktuellen Einblick in den Ernährungszustand eines Insekts gewährt, kann man annehmen, dass der die Proventrikelaktivität regulierende Faktor in der Hämolymphe zu finden ist. Das Ziel der vorliegenden Doktorarbeit war es, die gegenseitige Beeinflussung von Aufnahme (Futterqualität und –quantität), Verbrauch (Stoffwechselrate) und „internal state“ Variablen (Hämolymphosmolarität und –zuckerspiegel) zu untersuchen und herauszufinden, welcher dieser Faktoren die Aktivität des Proventrikels bei der Honigbiene kontrolliert. Zu diesem Zweck wurden frei fliegende Sammlerinnen trainiert, kontrollierte Mengen verschiedener Zuckerlösungen zu sammeln. Direkt nach dem Füttern wurden die Stoffwechsel-raten über bestimmte Zeiten gemessen, danach wurden Kropfentleerungsraten und Hämo-lymphzuckerspiegel der jeweiligen Bienen gemessen. Unter allen untersuchten Bedingungen waren sowohl die Zuckertransportraten durch den Proventrikel als auch die Hämolymphzuckerspiegel hauptsächlich von der Stoffwechselrate abhängig. Bei Bienen, die kontrollierte Mengen von 15-, 30- oder 50-prozentigen Saccharoselösungen gesammelt hatten, waren die Hämolymph-trehalose, -glucose und –fructosespiegel für Stoffwechselraten von 0 – 4,5 mlCO2/h konstant. Bei höheren Stoffwechselraten sank die Trehalosekonzentra-tion, während die von Glucose und Fructose stieg; eine Ausnahme stellten Bienen dar, denen 15-prozentige Saccharoselösung gefüttert worden war. Da die Zuckerversorgung aus dem Kropf über den Proventrikel ausreichte, um auch die höchsten Stoffwechselraten zu ermöglichen, müssen die beobachteten Verläufe von einer Limitierung des Fettkörpers hinsichtlich der Trehalosesynthese herrühren. Die maximale Umwandlungs-rate von Glucose zu Trehalose im Fettkörper wurde daher auf 92,4 µg Glucose/ Minute berechnet. Allerdings war sowohl die Umwandlungsrate von Glucose zu Trehalose als auch die Zuckertransportrate vom Kropf in den Mitteldarm bei Bienen limitiert, die 15-prozentige Saccharoselösungen gefüttert bekamen. Insgesamt führte das zu einem Absinken des Gesamt-Hämolymphzuckerspiegels bei Stoffwechselraten, die über 5 mlCO2/h lagen. Auch wenn die Sammlerinnen in der Lage waren ihre Zuckertransportrate genau an ihre Stoffwechselrate anzupassen, wurde unter bestimmten Bedingungen ein festgelegter Überschuss an Zuckern durch den Proventrikel transportiert. Dieser Überschuss an Zuckern vergrößerte sich mit zunehmender Konzentration und zunehmender Menge der gefütterten Zuck-erlösung, verkleinerte sich aber mit fortschreitender Zeit nach dem Füttern. Er war unab-hängig vom Stoffwechsel der Bienen und der Molarität und Viskosität der gefütterten Zuckerlösung. So lange die Bienen ihren Kropfinhalt nicht aufgebraucht hatten, waren die Hämolymphzuckerspiegel von dem Überschuss an transportiertem Zucker, von der Zeitspanne zwischen Füttern und Hämolymphentnahme sowie der Konzentration der gefütterten Lösung und deren Viskosität unbeeinflusst. Wenn die Bienen allerdings reine Glucose- (oder Fruc-tose-)lösungen gefüttert bekamen, wurde wesentlich weniger Fructose (oder Glucose) in der Hämolymphe gemessen, was zu niedrigeren Gesamt-Hämolymphzuckerspiegeln führte, während der Trehalosespiegel unbeeinflusst blieb. Um den Mechanismus zu untersuchen, der der Proventrikelregulierung unterliegt, wurden Sammlerinnen mit entweder verdaubaren (Glucose, Fructose oder Trehalose) oder unver-daubaren Zuckern (Sorbose) injiziert. Die Bienen reagierten auf die Injektionen der ver-daubaren Zucker mit einer Reduzierung der Kropfentleerungsrate, wohingegen die Injizierung nicht verdaubarer Zucker keinen Einfluss auf die Kropfentleerung hatte. Daraus wird geschlossen, dass die Proventrikelregulation von der Konzentration der verdaubaren Kompo-nenten in der Hämolymphe kontrolliert wird und nicht von der Hämolymph-osmolarität. Eine Zeitspanne von 10min reichte aus, um nach der Injektion reduzierte Kropfentleerungsraten zu beobachten. Es wird angenommen, dass Glucose und Fructose nur über die Umwandlung zu Trehalose einen Einfluss auf die Proventrikelaktivität haben. Wenn allerdings die Injektionen bereits 5min nach der Futteraufnahme stattfanden, wirkte sich das nicht auf die Kropfentleerungsrate aus. Weiterhin wurde untersucht, ob die Überregulation das Ergebnis einer „Vorschussregula-tion“ für den anstehenden Abflug und Flug ist. In einem ersten Experiment wurde untersucht, ob die Bienen diesen Überschuss erst direkt vor dem Abflug durch den Proventrikel lassen. In einem zweiten Experiment wurde untersucht, ob die Entfernung zwischen Stock und Futter-quelle einen Einfluss auf die Menge des transportierten Zuckerüberschusses hat. In einem dritten Experiment wurde untersucht ob laufende Bienen auch einen Überschuss an Zuckern durch den Proventrikel leiten, obwohl sie nicht fliegen müssen. Auch wenn wir nicht nach-weisen konnten, dass die Überregulation das Ergebnis einer Vorschussregulation für den anstehenden Abflug und Flug ist, ist es dennoch denkbar, dass dieses Phänomen eine festge-legte Reaktion der Sammlerinnen ist, die nicht moduliert werden kann. Um zu untersuchen, ob man auch bei Sammlerinnen, die von natürlichen Futterquellen kommen, regulierte Hämolymphzuckerspiegel findet, wurden deren Kropfinhalte und Hämolymphzuckerspiegel bestimmt. Während die Menge des gesammelten Nektars keinen Einfluss auf die Hämolymphzuckerspiegel hatte, hatten Sammlerinnen höhere Glucose-, Fructose- und Saccharosehämolymphzucker-spiegel, wenn der Nektar im Kropf höher konzentriert war. Im Gegensatz dazu wurde keine Beziehung zwischen Nektarkonzentration und Trehalosespiegel gefunden. Wir sind sicher, dass die Regulation des Futtertransports vom Kropf zum Mitteldarm über den Trehalosespiegel kontrolliert wird. Trotzdem ist die Bilanz zwischen Zuckertransportrate und Stoffwechsel nicht unter allen Bedingungen exakt ausgeglichen. Diese „Ungenauigkeit“ ist von denjenigen Faktoren abhängig, die einen Einfluss auf die Sammelenergetik der Sammlerinnen haben, aber unabhängig von den Faktoren, die keinen Einfluss auf die Sam-melenergetik haben. Daher nehmen wir an, dass die Proventrikelaktivität über die Motivation der Bienen moduliert werden kann.

Sphingolipids are important signaling molecules regulating cell growth, cell death and differentiation, thus making them important molecules in determining the fate of a cell and in the pathogenesis of chronic illnesses. The sphingolipid signaling pathway can be initiated by reactive oxygen species (ROS) and inflammatory molecules, both of which are believed to be upregulated in a state of obesity. The hypothesis tested in this dissertation is that due to the inflammatory state of obese animals, the sphingolipid pathway is altered, shifting the balance of pro- and anti-apoptotic proteins and contributing to the pathogenesis of diseases associated with an obese state. The specific aims were to compare, 1) key sphingolipid signaling enzymes; 2) levels of sphingolipid signaling molecules and 3) pro and anti-apoptotic protein levels, in hepatic and colonic tissues procured from lean and obese animals. Obese animals are susceptible to various diseases, including colon cancer and hepatic steatosis. To assess the effect of obesity on sphingolipid signaling, and to provide insight as to the pathogenesis of diseases in a state of obesity, liver and colon tissues from Zucker obese female rats (fa/fa) were compared to tissues from their lean counterparts (Fa/fa or Fa/Fa Zucker rats). Enzyme analyses included an assay of sphingomyelinase (SMase) activity and quantification of ceramidase and sphingosine kinase-1 (SK1) protein expression by western blot. Also, sphingomyelin (SM), ceramide, ceramide-1 phosphate (C1P), sphingosine and sphingosine-1-phosphate (S1P) levels were determined by high-performance liquid chromatography (HPLC) -tandem mass spectroscopy (MS). Representative apoptotic proteins, Bax and Bcl-2 were quantified by western blot. Obese liver demonstrates hepatic steatosis in the Zucker animal model. Among the major differences noted between obese and lean liver were significantly upregulated ceramidase, and downregulated SK1 and C1P levels (P<0.05), as well as a difference in ceramide and SM species composition. Bax was overexpressed while Bcl-2 level was lower in obese compared to lean liver (P<0.05). Taken together, the results indicate a shift toward higher apoptotic signaling in obese liver tissue and correspond with the diseased state of the steatotic liver. Analysis of the sphingolipid pathway in colon revealed upregulation of ceramidase and downregulation of SK1 (P<0.05), similar to liver tissue. C1P levels were lower (P<0.05) but no changes were observed for ceramide, SM or sphingosine levels. A trend toward higher SMase activity in obese colon was observed. Bax was overexpressed in obese colon tissue (P< 0.05), while Bcl-2 results were inconclusive. The liver expressed lower level of molecules associated with sphingolipid signaling than the colons. This study is first to demonstrate tissue-specific differences in the sphingolipid signaling pathway, regardless of genotype. Nevertheless, overall the genotype of Zucker model was found to be a factor altering the expression levels of various sphingolipid enzymes and metabolites in both colon and liver. The findings of the present research provide incentive to further understand the role and modulation of sphingolipid signaling pathway in causation and prevention of chronic diseases prevalent in obese state.

Sphingolipids are important signaling molecules regulating cell growth, cell death and differentiation, thus making them important molecules in determining the fate of a cell and in the pathogenesis of chronic illnesses. The sphingolipid signaling pathway can be initiated by reactive oxygen species (ROS) and inflammatory molecules, both of which are believed to be upregulated in a state of obesity. The hypothesis tested in this dissertation is that due to the inflammatory state of obese animals, the sphingolipid pathway is altered, shifting the balance of pro- and anti-apoptotic proteins and contributing to the pathogenesis of diseases associated with an obese state. The specific aims were to compare, 1) key sphingolipid signaling enzymes; 2) levels of sphingolipid signaling molecules and 3) pro and anti-apoptotic protein levels, in hepatic and colonic tissues procured from lean and obese animals. Obese animals are susceptible to various diseases, including colon cancer and hepatic steatosis. To assess the effect of obesity on sphingolipid signaling, and to provide insight as to the pathogenesis of diseases in a state of obesity, liver and colon tissues from Zucker obese female rats (fa/fa) were compared to tissues from their lean counterparts (Fa/fa or Fa/Fa Zucker rats). Enzyme analyses included an assay of sphingomyelinase (SMase) activity and quantification of ceramidase and sphingosine kinase-1 (SK1) protein expression by western blot. Also, sphingomyelin (SM), ceramide, ceramide-1 phosphate (C1P), sphingosine and sphingosine-1-phosphate (S1P) levels were determined by high-performance liquid chromatography (HPLC) -tandem mass spectroscopy (MS). Representative apoptotic proteins, Bax and Bcl-2 were quantified by western blot. Obese liver demonstrates hepatic steatosis in the Zucker animal model. Among the major differences noted between obese and lean liver were significantly upregulated ceramidase, and downregulated SK1 and C1P levels (P<0.05), as well as a difference in ceramide and SM species composition. Bax was overexpressed while Bcl-2 level was lower in obese compared to lean liver (P<0.05). Taken together, the results indicate a shift toward higher apoptotic signaling in obese liver tissue and correspond with the diseased state of the steatotic liver. Analysis of the sphingolipid pathway in colon revealed upregulation of ceramidase and downregulation of SK1 (P<0.05), similar to liver tissue. C1P levels were lower (P<0.05) but no changes were observed for ceramide, SM or sphingosine levels. A trend toward higher SMase activity in obese colon was observed. Bax was overexpressed in obese colon tissue (P< 0.05), while Bcl-2 results were inconclusive. The liver expressed lower level of molecules associated with sphingolipid signaling than the colons. This study is first to demonstrate tissue-specific differences in the sphingolipid signaling pathway, regardless of genotype. Nevertheless, overall the genotype of Zucker model was found to be a factor altering the expression levels of various sphingolipid enzymes and metabolites in both colon and liver. The findings of the present research provide incentive to further understand the role and modulation of sphingolipid signaling pathway in causation and prevention of chronic diseases prevalent in obese state.

Techn. University, Diss., 2001--Berlin.

Thesis (Ph. D.)--West Virginia University, 2008. / Title from document title page. Document formatted into pages; contains xiv, 195 p. : ill. (some col.). Includes abstract. Includes bibliographical references.

Orientadores: Laurecir Gomes, Licio Augusto Velloso / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-13T00:57:44Z (GMT). No. of bitstreams: 1 Biancalana_Adriano_D.pdf: 1382210 bytes, checksum: 7e965b9b049e72e0af3ee28fbf960b16 (MD5) Previous issue date: 2009 / Resumo: A obesidade é considerada hoje uma epidemia mundial. A obesidade é um dos maiores problemas de saúde pública em muitas partes do planeta, onde cresce em taxas alarmantes. No Brasil, a diminuição das taxas de desnutrição vieram acompanhadas pelo aumento das taxas de sobrepeso e obesidade. A obesidade pode ser definida como o acúmulo anormal ou excessivo de gordura, que pode prejudicar a saúde. A obesidade aumenta significativamente o risco do desenvolvimento de problemas de saúde como a hipertensão arterial, derrame, problemas respiratórios, diabetes Melitus (Tipo II), incidência de certas formas de câncer, doenças do coração, alterações músculo esqueléticas e osteoartrites das grandes e pequenas articulações. Sendo que a adiposidade está relacionada aos níveis individuais de gordura para cada individuo. A função dos tendões é transmitir a força criada nos músculos aos ossos, possibilitando o movimento articular. Os tendões são constituídos por células (tenócitos e tenoblastos) e por uma matriz extracelular desenvolvida, constituída por macromoléculas que interagem entre si e com a célula que a produz. A matriz extracelular dos tendões é constituída por colágeno, proteoglicanos e proteínas não colagênicas. Este trabalho objetivou analisar as alterações morfológicas, bioquímicas e biomecânicas do tendão do músculo flexor digital profundo em ratos Zucker geneticamente obesos (fa/fa) e dos animais magros (Fa/_). Os ratos Zucker possuem receptores para leptina não funcionais, e devido a isso desenvolvem obesidade. A avaliação histológica não revelou diferenças, assim como os testes imunohistoquímicos para colágeno do tipo III, nos tendões de ambos os grupos. Na análise ultraestutural do tendão de ambos os animais foram observadas gotículas de lipídio ao longo dos feixes de fibrilas de colágeno. Somente os animais obesos apresentaram fibrilas de colágeno desorganizadas, diferente da distribuição típica esperada para o tecido. O diâmetro das fibrilas de colágeno apresentou distribuição e diâmetro de massa-médio diferente entre os dois grupos. Com relação aos parâmetros mecânicos houve diferença significativa com relação ao deslocamento e a deformação máxima. Os animais obesos apresentaram conteúdo maior de hidroxiprolina enquanto os animais magros apresentaram maior quantidade de proteínas não colagênica e de glicosaminoglicanos. Devido ao elevado sobrepeso e as características do tendão dos animais obesos pode ser concluído que a influência da obesidade sobre os tendões provoca alterações na constituição e organização dos componentes da matriz extracelular. Alterações estas que podem ser relacionadas a modificações organizacionais e estruturais dos feixes de colágeno, influenciando as propriedades mecânicas do tendão e a evolução para um estado patológico. / Abstract: Obesity is considered a worldwide epidemic, one of the biggest public health problems in many parts of the planet, which grows in alarming rates. In Brazil, the decline in rates of malnutrition has been accompanied by rising rates of overweight and obesity, which can be defined as the accumulation of abnormal or excessive fat which presents a risk to health. Obesity significantly increases the risk of developing health problems as hypertension, stroke, respiratory problems, diabetes, cancer, cardiovascular diseases, skeletal muscle alteration and osteoarthritis. The tendons transmit the strength created in muscles to bones, allowing the joints movement. Tendons consist of cells (tenocyte and tenoblast) and an abundant extracellular matrix composed by collagen, proteoglycans and non-collagenous proteins. This study aimed to analyze the morphological, biochemical and biomechanical alterations of the deep digital flexor tendon in Zucker rats genetically obese (fa/fa) and of lean animals (Fa/_). Histological evaluation and immunohistochemical tests for collagen type III, showed no differences in tendons of both groups. Ultrastructural analysis, showed presence of lipid droplets on the bundles collagen. Only the obese animals showed disorganization in the distribution of fibrils. The diameter of collagen fibrils presented different distribution and mass-average diameter between the two groups, being bimodal in lean rats and unimodal in obese rats. With regard to mechanical parameters significant difference was observed, larger maximum displacement and strain in obese animals. The obese animals presented higher content of hydroxyproline while lean animals showed a larger amount of non-collagenous proteins and glycosaminoglycans. Due to the high overweight of the obese animals can be concluded that the obesity causes changes in the composition and organization of extracellular matrix of the tendon. These alterations may be related to organizational and structural changes of collagen bundles, influencing the mechanical properties of tendon and developments toward a pathological condition. / Doutorado / Biologia Celular / Doutor em Biologia Celular e Estrutural

Das Phloem stellt ein Netzwerk zur Assimilat- und Nährstofftranslokation sowie zur elektrischen Kommunikation innerhalb der Pflanze dar. In apoplastisch beladenden Pflanzen werden die funktionellen Eigenschaften des Phloems im Wesentlichen vom Zusammenspiel eines Transportmoduls, bestehend aus Carriern, Kaliumkanälen und Protonen-ATPasen, bestimmt. Ausgangspunkt für die biophysikalische Charakterisierung dieses Phloem-Transportmoduls waren Arbeiten zum Saccharosetransport in der Arabidopsis akt2/3-1 Mutante. Das AKT2/3 Gen kodiert für einen Phloem-spezifischen Kaliumkanal vom Shaker-Typ. Die Tatsache, dass der Saccharosegehalt im Phloem dieser Mutante um 50% im Vergleich zum Wildtyp reduziert war, ließ eine enge Kopplung von Kalium- und Zuckerflüssen vermuten. Um diesen Phänotyp aufklären zu können und ein Modell für die Beladungsprozesse an der Phloemmembran zu entwickeln, wurde das heterologe Expressionssystem der Xenopus Oozyten gewählt. So konnte in Coexpressionsstudien die Interaktion von Phloem-lokalisierten Kaliumkanälen und Transportern sowie die Kopplung des Kalium- und Zuckertransports mit Hilfe biophysikalischer Methoden untersucht werden. / In plants the phloem tissue constitutes a network providing for assimilate and nutrient translocation as well as electrical communication. A transport module, consisting of carriers, channels and pumps plays a pivotal role in apoplasmically loading plant species and determines the specific transport properties of phloem cells. The AKT2/3 channel represents a phloem-specific Shaker-like K+ channel of the model plant Arabidopsis thaliana. Based on the observation, that sucrose transport is severely impaired in the corresponding akt2/3-1 mutant, we hypothesised a tight coupling of potassium and sugar fluxes during phloem loading. In order to allow a biophysical characterisation of the transport processes at the phloem plasma membrane during sugar loading, we decided to employ Xenopus oocytes as a model system for the heterologous expression of phloem transport proteins.

The overall objective of this research was to investigate the status of tumor necrosis factor-α (TNF-α), and molecules associated with its signaling, in the pathological state of hepatic steatosis. The effect of NSAID piroxicam, a cancer preventive agent also known to affect TNF-α signaling on hepatic steatosis, was also investigated. The biological state of the tissue was assessed by examining the expression of TNF-α signaling molecule in whole tissue, as well as in hepatic lipid raft. Lipid rafts are dynamic assemblies of cholesterol and sphingolipids, microdomains that form in the exoplasmic leaflet of the biological membranes shown to play a role in compartmentalization, modulation and integration of the cell signaling. In the present research, Zucker obese rats were used as a model of human obesity and insulin resistant state. These rats exhibit hepatic steatosis in adulthood similar to those noted in obese individuals. Female Zucker obese and lean rats (5 weeks old) were fed a semisynthetic diet with or without piroxicam (150 ppm). Zucker lean counterparts served as control. After 8 weeks of feeding, rats were euthanized and liver from each animal was collected. Liver tissue from each animal was processed for histology and biochemical analysis which included lipids and proteins (COX-1 and 2, TNF-α, TNF-RI and RII, IKK-β, IκB-α and NF-κB). Liver histology and the level of total lipids confirmed that Zucker obese rats had hepatic steatosis, which was further augmented by piroxicam treatment. Whole tissue protein expression, using western blot, showed that the steatotic liver differed from non-steatotic livers by having lower levels of TNF-RII. TNF-RII showed a trend which was inversely proportional to the pathological state of the tissue. The obese-piroxicam liver had the lowest level of TNF-RII and lean livers had the highest (p<0.05). The total NF-κB level was higher in the obese and obese-piroxicam groups compared to the lean or lean-piroxicam groups (p<0.05). Piroxicam treatment lowered the level of NF-κB in obese and lean livers. IκB-α was higher in obese livers than in lean livers. The nuclear level of NF-κB by western blot analysis showed the same pattern as noted in the whole tissue homogenate. However, the difference in the level between obese and lean was marked. The obese nuclei contained two to three fold higher levels of NF-κB protein than the lean liver nuclei. IκB-α level was significantly higher in the obese liver tissues and nuclei than their lean counterparts. While transcriptionally active NF-κB was higher (p<0.05) in the obese livers than in the lean livers, the difference between obese and lean groups was not as significant as that noted for the level of NF-κB assessed by western blot. This suggests that the proportion of active NF-κB present in the nuclear fraction is much higher in the lean than in the obese nuclei. Lipid raft was extracted and identified successfully from obese and lean livers. The total caveolin and flotillin levels were significantly higher in the liver lipid rafts of the obese-piroxicam than that of the other groups. This is the group that also exhibited higher steatosis. Piroxicam treatment significantly decreased the level of caveolin in the lean liver and significantly increased the level of flotillin in the obese liver. While COX-1 was not detectable, however, the level of COX-2 and TNF-RII in lipid raft was opposite to the level noted in the whole tissue homogenate. TNFRII was highest in the obese-piroxicam lipid raft and lowest in the lean-piroxicam lipid raft. TNF-RII, COX-2, IκB-α and NF-κB proteins were the molecules profoundly affected by the pathological state of the tissue and piroxicam treatment. This research is the first to report the presence of IκB-α in the nuclear compartment with a higher level in the nuclei and whole tissue in the obese liver than in the lean liver. This research demonstrates that TNF-α to NF-κB axis is altered in steatotic liver, and analysis of lipid rafts in steatotic and non-steatotic liver demonstrates that lipid rafts play a distinct role in modifying the biological availability of key proteins in the pathological state of liver steatosis.

Diabetes mellitus (DM) and hyperglycemia contribute to sympathetic nervous system (SNS) activation and cardiovascular dysfunction. SNS activation and increased norepinephrine levels downregulate cardiac β-adrenergic receptors (β-AR). The ADMIRE-HF trial identified reduced cardiac SNS innervation as an independent prognostic marker in heart failure. The β-AR antagonist [3H]-CGP12177 was used to quantify cardiac β-AR in ex vivo biodistribution studies in streptozotocin (STZ)-treated rats after 8 weeks of sustained hyperglycemia, and in the Zucker Diabetic Fatty (ZDF) rat model of type-2 diabetes at the onset of hyperglycemia (10 weeks of age) and after a sustained period of hyperglycemia (16 weeks of age). In some STZ rats, insulin was provided at the onset of hyperglycemia, or after a sustained period of hyperglycemia. Insulin treatment at both time points prevented reduced [3H]-CGP12177 binding (33-38% compared to controls) observed in STZ hyperglycemics. ZDF β-ARs were intact at 10 weeks but became reduced (16-25% relative to the Zucker leans) following 6 weeks of hyperglycemia. This work supports that cardiac β-AR are reduced in models of DM and that restoring insulin signalling to maintain glycemic control can normalize β-AR density whether provided early or after a period of sustained hyperglycemia.